Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
940.7 INR | -1.18% | -1.73% | +45.08% |
05-23 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
05-22 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
Chart calendar Strides Pharma Science Limited
Upcoming events on Strides Pharma Science Limited
Past events on Strides Pharma Science Limited
22/05/2024 11:00 | Q4 2024 Earnings Call |
22/05/2024 09:13 | Q4 2024 Earnings Release |
30/01/2024 10:30 | Q3 2024 Earnings Call |
30/01/2024 07:46 | Q3 2024 Earnings Release |
30/10/2023 10:30 | Q2 2024 Earnings Call |
30/10/2023 06:58 | Q2 2024 Earnings Release |
25/09/2023 12:30 | Investor Meeting |
28/08/2023 08:00 | Annual General Meeting |
03/08/2023 | Détachement de for final dividend |
02/08/2023 11:30 | Q1 2024 Earnings Call |
02/08/2023 07:21 | Q1 2024 Earnings Release |
25/05/2023 11:30 | Q4 2023 Earnings Call |
25/05/2023 09:50 | Q4 2023 Earnings Release |
06/02/2023 07:00 | Extraordinary Shareholders Meeting |
24/01/2023 11:00 | Q3 2023 Earnings Call |
24/01/2023 09:11 | Q3 2023 Earnings Release |
14/11/2022 11:30 | Interim 2023 Earnings Call |
14/11/2022 09:47 | Interim 2023 Earnings Release |
09/09/2022 08:00 | Annual General Meeting |
29/07/2022 11:30 | Q1 2023 Earnings Call |
Past dividends on Strides Pharma Science Limited
03/08/2023 | Annual 1.5 INR |
04/08/2021 | Annual 2.5 INR |
23/07/2020 | Final Payment 2 INR |
21/08/2019 | Interim Payment 12 INR |
18/07/2019 | Annual 3 INR |
11/09/2018 | Annual 2 INR |
06/09/2017 | Annual 4.5 INR |
20/07/2016 | Annual 4 INR |
21/07/2015 | Annual 3 INR |
15/10/2014 | Bonus Payment 105 INR |
Annual results
Fiscal Period | March | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 30 117 30 506 -1.28% | 27 520 28 873 -4.69% | 33 159 32 807 1.07% | 30 703 30 796 -0.3% | 36 884 35 958 2.58% | 40 511 41 139 -1.53% |
EBITDA Million INR | Released Forecast Spread | 4 548 4 485 1.38% | 5 347 6 176 -13.42% | 6 268 6 482 -3.3% | -103 -148 30.26% | 4 302 3 893 10.52% | 7 433 7 367 0.9% |
EBIT Million INR | Released Forecast Spread | 2 829 2 721 3.96% | 3 610 4 427 -18.46% | 4 205 4 355 -3.44% | -2 531 -2 397 -5.6% | 1 869 1 588 17.71% | 5 226 5 234 -0.16% |
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 1 204 1 047 14.96% | 1 619 3 826 -57.68% | 3 733 2 820 32.38% | -5 417 -5 321 -1.8% | -2 862 -33,5 -8443.28% | 0,00 0,00 - |
Net income Million INR | Released Forecast Spread | 3 246 3 358 -3.33% | 364 2 621 -86.12% | 2 684 2 348 14.33% | -4 602 -4 941 6.87% | -2 026 205 -1088.46% | -706 -414 -70.77% |
EPS INR | Released Forecast Spread | 36,2 34,3 5.66% | 4,06 24,1 -83.18% | 29,9 24,6 21.63% | -51,3 -45,1 -13.7% | -22,5 -26,8 16.08% | -7,76 -4,60 -68.7% |
Announcement Date | 10/05/19 | 20/05/20 | 27/05/21 | 24/05/22 | 25/05/23 | 22/05/24 |
Quarterly results
Fiscal Period | March | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million INR | Released Forecast Spread | 9 085 8 594 5.71% | 6 884 8 741 -21.25% | 7 215 7 748 -6.88% | 7 944 7 733 2.73% | 8 660 8 260 4.84% | 9 401 8 976 4.74% | 8 971 9 818 -8.63% | 8 648 9 966 -13.22% | 9 864 8 871 11.19% | 9 300 10 202 -8.84% | 9 833 | 10 216 | 10 799 |
EBITDA Million INR | Released Forecast Spread | 1 592 1 721 -7.48% | -554 1 532 -136.13% | -10,8 353 -103.05% | 46,1 312 -85.26% | 415 246 68.94% | 602 609 -1.28% | 981 931 5.4% | 1 163 1 214 -4.17% | 1 556 1 204 29.2% | 1 666 1 567 6.35% | 1 793 | 2 096 | 1 951 |
EBIT Million INR | Released Forecast Spread | 1 073 1 135 -5.44% | -1 102 1 056 -204.39% | -576 -415 -38.88% | -563 -103 -446.51% | -185 -133 -39.19% | -2,47 107 -102.31% | 364 438 -16.83% | 561 726 -22.7% | |||||
Earnings before Tax (EBT) Million INR | Released Forecast Spread | 759 911 -16.7% | -2 246 791 -383.92% | -1 514 -675 -124.26% | -1 069 -338 -216.16% | -589 535 -210.06% | -1 070 -143 -648.34% | 67,7 218 -68.96% | 654 566 15.61% | |||||
Net income Million INR | Released Forecast Spread | 461 686 -32.82% | -2 052 529 -487.9% | -1 626 -744 -118.49% | -1 217 -534 -127.85% | 292 482 -39.38% | -1 359 -301 -351.47% | 228 22,0 937.5% | -800 326 -345.48% | |||||
Announcement Date | 27/05/21 | 06/08/21 | 10/11/21 | 10/02/22 | 24/05/22 | 29/07/22 | 14/11/22 | 24/01/23 | 25/05/23 | 02/08/23 | - | - | - |
Past sector events for Strides Pharma Science Limited
28/05/2024 16:53 | WOCKHARDT LIMITED: Q4 2024 Earnings Release |
24/05/2024 15:54 | GLENMARK PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release |
22/05/2024 10:35 | SUN PHARMACEUTICAL INDUSTRIES LTD.: Q4 2024 Earnings Release |
22/05/2024 09:13 | STRIDES PHARMA SCIENCE LIMITED: Q4 2024 Earnings Release |
19/05/2024 07:46 | MIDDLE EAST PHARMACEUTICAL INDUSTRIES COMPANY: Q1 2024 Earnings Release |
17/05/2024 11:10 | ZYDUS LIFESCIENCES LIMITED: Q4 2024 Earnings Release |
16/05/2024 09:25 | CAPLIN POINT LABORATORIES LIMITED: Q4 2024 Earnings Release |
16/05/2024 07:15 | KRKA, D. D.: Q1 2024 Earnings Release |
15/05/2024 | SAM CHUN DANG PHARM. CO., LTD: Q1 2024 Earnings Release |
15/05/2024 | CELLTRION PHARM, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- STAR Stock
- STAR Stock
- Calendar Strides Pharma Science Limited